Tsukui Takunori, Sakakura Kenichi, Taniguchi Yousuke, Yamamoto Kei, Seguchi Masaru, Wada Hiroshi, Momomura Shin-Ichi, Fujita Hideo
Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan.
Intern Med. 2020;59(13):1597-1603. doi: 10.2169/internalmedicine.4287-19. Epub 2020 Jul 1.
Objective In primary percutaneous coronary intervention (PCI), the door-to-balloon time (DTBT) is known to be associated with in-hospital death in patients with ST-segment elevation myocardial infarction (STEMI). However, little is known regarding the association between the DTBT and the mid-term clinical outcomes in patients with STEMI. The purpose of this study was to investigate the association between the DTBT and mid-term all-cause death. Methods The study population included 309 STEMI patients, who were divided into the short DTBT (DTBT<60 minutes, n=103), intermediate DTBT (DTBT 60-120 minutes, n=174) and long DTBT (DTBT >120 minutes, n=32) groups. The median follow-up period was 287 days (interquartile range: 182-624 days). Results The incidence of all-cause death in the long DTBT group was significantly higher in comparison to the other groups (p<0.001). In the multivariate Cox regression analysis, although a short DTBT [vs. intermediate DTBT: hazard ratio (HR) 1.00, 95% confidence interval (CI) 0.39-2.55, p=0.99] was not associated with all-cause death, a long DTBT (vs. intermediate DTBT: HR 2.80, 95% CI 1.26-6.17, p=0.011) was significantly associated with all-cause death, after controlling for confounding factors such as Killip class 4, an impaired renal function, and the number of diseased vessels. Conclusion The DTBT was significantly associated with the incidence of mid-term all-cause death. Our results support the strong adherence to the DTBT in patients with STEMI.
目的 在直接经皮冠状动脉介入治疗(PCI)中,已知门球时间(DTBT)与ST段抬高型心肌梗死(STEMI)患者的院内死亡相关。然而,关于DTBT与STEMI患者中期临床结局之间的关联知之甚少。本研究的目的是调查DTBT与中期全因死亡之间的关联。方法 研究人群包括309例STEMI患者,他们被分为短DTBT组(DTBT<60分钟,n=103)、中DTBT组(DTBT 60 - 120分钟,n=174)和长DTBT组(DTBT>120分钟,n=32)。中位随访期为287天(四分位间距:182 - 624天)。结果 与其他组相比,长DTBT组的全因死亡发生率显著更高(p<0.001)。在多变量Cox回归分析中,虽然短DTBT [与中DTBT相比:风险比(HR)1.00,95%置信区间(CI)0.39 - 2.55,p=0.99]与全因死亡无关,但在控制了诸如Killip分级4级、肾功能受损和病变血管数量等混杂因素后,长DTBT(与中DTBT相比:HR 2.80,95% CI 1.26 - 6.17,p=0.011)与全因死亡显著相关。结论 DTBT与中期全因死亡的发生率显著相关。我们的结果支持对STEMI患者严格遵守DTBT。